Observational evidence for detrimental impact of inhaled ozone on human respiratory system.
Causative influence
Convergent cross mapping method
Inhaled ozone
Respiratory disease
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
23 05 2023
23 05 2023
Historique:
received:
15
09
2022
accepted:
16
05
2023
medline:
25
5
2023
pubmed:
24
5
2023
entrez:
23
5
2023
Statut:
epublish
Résumé
The detrimental influence of inhaled ozone on human respiratory system is ambiguous due to the complexity of dose response relationship between ozone and human respiratory system. This study collects inhaled ozone concentration and respiratory disease data from Shenzhen City to reveal the impact of ozone on respiratory diseases using the Generalized Additive Models (GAM) and Convergent Cross Mapping (CCM) method at the 95% confidence level. The result of GAM exhibits a partially significant lag effect on acute respiratory diseases in cumulative mode. Since the traditional correlation analysis is incapable of capturing causality, the CCM method is applied to examine whether the inhaled ozone affects human respiratory system. The results demonstrate that the inhaled ozone has a significant causative impact on hospitalization rates of both upper and lower respiratory diseases. Furthermore, the harmful causative effects of ozone to the human health are varied with gender and age. Females are more susceptible to inhaled ozone than males, probably because of the estrogen levels and the differential regulation of lung immune response. Adults are more sensitive to ozone exposure than children, potentially due to the fact that children need longer time to react to ozone stress than adults, and the elderly are more tolerant than adults and children, which may be related to pulmonary hypofunction of the elderly while has little correlation with ozone exposure.
Identifiants
pubmed: 37221507
doi: 10.1186/s12889-023-15902-6
pii: 10.1186/s12889-023-15902-6
pmc: PMC10204295
doi:
Substances chimiques
Ozone
66H7ZZK23N
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
929Informations de copyright
© 2023. The Author(s).
Références
Int J Environ Res Public Health. 2014 Jan 03;11(1):713-33
pubmed: 24394218
Am J Epidemiol. 2002 Aug 1;156(3):193-203
pubmed: 12142253
Int J Environ Res Public Health. 2014 May 06;11(5):4799-824
pubmed: 24806191
BMJ. 2003 Jan 25;326(7382):219
pubmed: 12543843
Front Immunol. 2020 Sep 02;11:1957
pubmed: 32983127
Inhal Toxicol. 2001 Jun;13(6):465-83
pubmed: 11445887
Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L142-50
pubmed: 17400600
Environ Res. 2016 Jan;144(Pt A):99-105
pubmed: 26599588
PLoS One. 2011 Mar 31;6(3):e18295
pubmed: 21483839
Environ Res. 2015 Feb;137:1-7
pubmed: 25483412
Epidemiology. 2001 Mar;12(2):200-8
pubmed: 11246581
J Expo Sci Environ Epidemiol. 2015 Sep-Oct;25(5):532-42
pubmed: 25004934
Toxicol Sci. 2009 Feb;107(2):535-43
pubmed: 19066396
Sci Total Environ. 2012 Jun 1;426:83-9
pubmed: 22521098
Science. 2012 Oct 26;338(6106):496-500
pubmed: 22997134
Sci Rep. 2017 Jan 13;7:40482
pubmed: 28084399
Environ Sci Pollut Res Int. 2022 Apr;29(19):28816-28828
pubmed: 34989991
Lancet Respir Med. 2017 Sep;5(9):691-706
pubmed: 28822787
Environ Geochem Health. 2020 Oct;42(10):3317-3331
pubmed: 32367271
Environ Int. 2023 Jan;171:107666
pubmed: 36470122
Environ Health Perspect. 2008 Sep;116(9):1183-8
pubmed: 18795161
BMC Public Health. 2022 Dec 5;22(1):2265
pubmed: 36464692
Chemosphere. 2013 Oct;93(6):899-905
pubmed: 23786810
PeerJ. 2015 Mar 05;3:e824
pubmed: 25780776
PeerJ. 2021 Apr 13;9:e11066
pubmed: 33954029